This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Illumina Inc (ILMN)

NASDAQ: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 353.35M 125.31M 151.25M 86.63M
Operating Gains/Losses -87.79M -79.59M -21.57M 56.75M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -50.38M -15.93M -34.44M -7.01M
(Increase) Decrease in Inventories -36.54M 6.22M -23.71M 22.15M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -2.11M 2.39M 15.11M -21.10M
(Decrease) Increase In Other Current Liabilities 60.33M 171.48M 24.39M 42.95M
(Increase) Decrease In Other Working Capital -34.40M -12.54M 3.74M 2.05M
Other Non-Cash Items 41.69M 89.80M 103.06M 58.07M
Net Cash From Continuing Operations 501.27M 386.42M 291.87M 358.14M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 501.27M 386.42M 291.87M 358.14M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 812.83M 898.75M 1.06B
Purchases of Property, Plant & Equipment -142.22M -90.56M -81.01M -79.55M
Acquisitions -3.29M -523.50M -83.16M -58.30M
Purchases of Short-Term Investments 0.00 -364.00M -925.48M -1.31B
Other Cash from Investing Activities -11.76M 0.00 6.00M 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -406.62M -69.65M -150.01M -401.00M
Issuance of Debt 1.13B 0.00 0.00 903.49M
Cash Used for Financing Activities
Issuance of Capital Stock 96.33M 94.46M 54.36M 67.45M
Repayment of Long-Term Debt -1.27B 0.00 0.00 -349.87M
Repurchase of Capital Stock -237.18M -50.02M -82.52M -570.41M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 116.44M -83.16M 17.41M 46.35M
Net Cash From Financing Activities -166.75M -38.72M -10.76M 97.02M
Effect of Exchange Rate Changes -3.38M -397.00K -103.00K -126.00K
Net Change in Cash & Cash Equivalents -75.48M 277.66M 131.00M 54.03M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for ILMN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 10 13 13
Moderate Buy 0 0 0 0
Hold 8 8 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

ILMN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs